Table 1 Patient clinical characteristics

Baseline characteristics

Age, years

67 ± 9

Male, n (%)

42 (81)

Body mass index, kg/m²

23.5 (22.3–26.2)

Hypertension, n (%)

47 (90)

Diabetes mellitus, n (%)

22 (42)

Current smoker, n (%)

10 (19)

Family history of premature CAD, n (%)

9 (17)

Chronic kidney disease, n (%)

11 (21)

Laboratory data

LDL-C, mg/dL

68 (56–89)

HDL-C, mg/dL

45 (37–56)

LDL-C to HDL-C ratio

1.6 (1.1–2.2)

Triglyceride, mg/dL

107 (80–155)

Hemoglobin A1c, %

6.0 (5.7–6.6)

Estimated GFR, mL/min/1.73 m²

69 (62–86)

Pre-procedural hs-cTnT, ng/mL

0.010 (0.007–0.019)

Medications

Aspirin use, n (%)

52 (100)

P2Y₁₂ receptor inhibitor use, n (%)

52 (100)

β-blocker use, n (%)

31 (60)

ACE-i / ARB use, n (%)

26 (50)

Statin use, n (%)

52 (100)

Ezetimibe, n (%)

26 (50)